Última actualización 15 de agosto de 2026
Key finding
Mean difference in HbA1c levels was -0.09 (95% CI: -0.55, 0.38)
This study evaluated the feasibility of implementing evidence-based clinical practice guidelines for managing Type 2 Diabetes in Ayurveda centers, finding no statistically significant differences in key outcomes.
Quick read
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Risk of bias
Some Concerns
Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.
Plain-language summary
A plain-language read of the study’s main message and where it applies.
Study focus
This study evaluated the feasibility of implementing evidence-based clinical practice guidelines for managing Type 2 Diabetes in Ayurveda centers, finding no statistically significant differences in key outcomes.
Understanding the effectiveness of evidence-based guidelines in alternative medicine settings is crucial for improving diabetes management. This study highlights the challenges in achieving significant health improvements and adherence in Ayurveda centers, which may inform future interventions and adaptations of clinical guidelines.
No statistically significant differences in primary outcomes. Partial adherence to EB-CPG recommendations among practitioners. Limited generalizability due to the specific population and setting.
Published in
Publication details and source links for this paper.
Kaushik C, Shristi K, Haiquan W, et al. A Two-Arm Feasibility Cluster Randomized Controlled Trial of Evidence-Based Clinical Practice Guidelines for Managing Type 2 Diabetes in Ayurveda Centers. Journal of Diabetes Research. 2026;2026:2602864. doi:10.1155/jdr/2602864
HbA1c levels were lower in the intervention group, but not statistically significant (-0.09%).
Fasting plasma glucose levels were lower in the intervention group, but not statistically significant (-1.86 mg/dL).
Health-related quality of life was higher in the intervention group, but not statistically significant (0.02 score).
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Evidence-Based Clinical Practice Guideline (EB-CPG) for T2DM Management and Fasting Plasma Glucose (FPG), HbA1c, Health-related quality of life.
This study contributes evidence to
Primary intervention
Evidence-Based Clinical Practice Guideline (EB-CPG) for T2DM Management
Primary outcomes
Primary intervention
Primary outcomes
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
4
Related topics
3
Evidence pairs
1617
Related studies
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.
Evidencia principal
Tema de evidencia
matched_outcome
Evidencia relacionada
Tema de evidencia
Guardar evidencia
Core evidence
The primary outcomes reported in this study.
Evidence-Based Clinical Practice Guideline (EB-CPG) for T2DM Management → Fasting Plasma Glucose (FPG)
Evidence-Based Clinical Practice Guideline (EB-CPG) for T2DM Management → Fasting Plasma Glucose (FPG)
Evidence-Based Clinical Practice Guideline (EB-CPG) for T2DM Management → HbA1c
Evidence-Based Clinical Practice Guideline (EB-CPG) for T2DM Management → HbA1c
Evidence-Based Clinical Practice Guideline (EB-CPG) for T2DM Management → Health-related quality of life
Evidence-Based Clinical Practice Guideline (EB-CPG) for T2DM Management → Health-related quality of life
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Evidence-Based Clinical Practice Guideline (EB-CPG) for T2DM Management and Fasting Glucose, Evidence-Based Clinical Practice Guideline (EB-CPG) for T2DM Management and HbA1c.
This study contributes to the evidence on the following intervention-outcome relationships.
Behavioral & Lifestyle
Behavioral & Lifestyle
Behavioral & Lifestyle
Curated evidence collections and hubs this study is part of.
All studies on Evidence-Based Clinical Practice Guideline (EB-CPG) for T2DM Management
Contributes to Evidence-Based Clinical Practice Guideline (EB-CPG) for T2DM Management evidence base.
All studies measuring Fasting Glucose
Measures Fasting Glucose as a key outcome.
All studies measuring HbA1c
Measures HbA1c as a key outcome.
All studies measuring Quality of Life Outcomes
Measures Quality of Life Outcomes as a key outcome.
Latest published studies
Published within the last 2 years.
Jump to pre-filtered views in Evidence Explorer.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Current evidence does not show a clear benefit of Evidence-Based Clinical Practice Guideline (EB-CPG) for T2DM Management for fasting plasma glucose (FPG).
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Fasting Plasma Glucose (FPG)
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Evidence-Based Clinical Practice Guideline (EB-CPG) for T2DM Management for HbA1c.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Evidence-Based Clinical Practice Guideline (EB-CPG) for T2DM Management for health-related quality of life.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Health-related quality of life
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Follow the topics this study contributes to.
Open broader Evidence Explorer views for this relationship.
Read related research summaries.
Centrada en la evidencia, no en la publicidad.
Tus datos siempre están protegidos.
Se agregan nuevos estudios todos los días.
